Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Neurofibromatosis 1 19Melanoma 11Neurofibroma, Plexiform 10Lung Neoplasms 8Neoplasms 7Neoplasm Metastasis 7Colorectal Neoplasms 7Breast Neoplasms 7Solid Tumours 5Pancreatic Neoplasms 5Carcinoma, Hepatocellular 4Uveal Melanoma 3Triple Negative Breast Neoplasms 3Thyroid Neoplasms 3Rectal Neoplasms 3Neurofibrosarcoma 3Gallbladder Neoplasms 3Colonic Neoplasms 3Biliary Tract Neoplasms 3Thyroid Cancer, Papillary 2Sarcoma 2Bile Duct Neoplasms 2Adult Solid Neoplasm 2Thyroid Diseases 1Thymoma 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Renal Insufficiency 1

Interventions

Bevacizumab 5Everolimus 4Sirolimus 2Lapatinib 2HDAC-42 2vistusertib 1temsirolimus 1neratinib 1icotinib 1emvododstat 1brolucizumab 1brigatinib 1aflibercept 1Vascular Endothelial Growth Factor A 1Valproic Acid 1Sunitinib 1Magnetic Resonance Imaging 1Immunoglobulin G 1Endostatins 1Doxycycline 1Disulfides 1Crizotinib 1Cetuximab 1Axitinib 1Aspirin 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neurofibromatosis 2 × AZD 6244 × Clear all
NCT03095248 2025-04-22

SEL-TH-1601

Children's Hospital Medical Center, Cincinnati

Phase 2 Terminated
10 enrolled 9 charts
CNS

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡